116 related articles for article (PubMed ID: 7583390)
1. Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease.
Weiner MA; Landmann RG; DeParedes L; Leventhal BG
J Pediatr Hematol Oncol; 1995 Nov; 17(4):338-41. PubMed ID: 7583390
[TBL] [Abstract][Full Text] [Related]
2. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; van der Schueren E
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):197-210. PubMed ID: 6368491
[TBL] [Abstract][Full Text] [Related]
3. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
4. [Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82].
Schellong G; Brämswig J; Ludwig R; Gerein V; Jobke A; Jürgens H; Kabisch H; Stollmann B; Weinel P; Gadner H
Klin Padiatr; 1986; 198(3):137-46. PubMed ID: 3523020
[TBL] [Abstract][Full Text] [Related]
5. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
6. Splenic reticuloendothelial function in children with cancer.
Buchanan GR; Holtkamp CA
J Pediatr; 1985 Feb; 106(2):239-42. PubMed ID: 2982005
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
8. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Hull MC; Mendenhall NP; Colgan ME
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
[TBL] [Abstract][Full Text] [Related]
9. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
10. Functional hyposplenia after splenic irradiation for Hodgkin's disease.
Coleman CN; McDougall IR; Dailey MO; Ager P; Bush S; Kaplan HS
Ann Intern Med; 1982 Jan; 96(1):44-7. PubMed ID: 7053701
[TBL] [Abstract][Full Text] [Related]
11. The effect of abdominal radiation on spleen function: a study in children with Wilms' tumor.
Stevens M; Brown E; Zipursky A
Pediatr Hematol Oncol; 1986; 3(1):69-72. PubMed ID: 2856389
[TBL] [Abstract][Full Text] [Related]
12. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
Powlis WD; Mauch P; Goffman T; Goodman RL
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1437-42. PubMed ID: 3305442
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
[TBL] [Abstract][Full Text] [Related]
15. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
[TBL] [Abstract][Full Text] [Related]
16. A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report.
Casper JT; Koethe S; Rodey GE; Thatcher LG
Blood; 1976 Feb; 47(2):183-8. PubMed ID: 1244917
[TBL] [Abstract][Full Text] [Related]
17. [Graded chemotherapy and reduced radiotherapy in Hodgkin's disease in childhood. Intermediate report on the cooperative HD 82 therapy study].
Strauch S; Schellong G; Wannenmacher M
Onkologie; 1984 Aug; 7(4):217-9. PubMed ID: 6384865
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
19. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
20. The treatment of stage IIIA Hodgkin's disease.
Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
